Security key
803607100
Sarepta Therapeutics, Inc. - Common Stock (SRPT)
CUSIP: 803607100
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,070,763
- Total 13F shares
- 93,387,845
- Share change
- +7,676,440
- Total reported value
- $2,009,593,455
- Put/Call ratio
- 133%
- Price per share
- $21.52
- Number of holders
- 343
- Value change
- +$171,390,517
- Number of buys
- 199
- Number of sells
- 129
Report period
Q4 2025
Institutions
343
Top holders
10
SRPT full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Sarepta Therapeutics, Inc. SEC filings
Sarepta Therapeutics, Inc. company facts
Sarepta Therapeutics, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 803607100
Recent filing periods:
Top shareholders of SRPT - Sarepta Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13D/G
13F
|
Company |
13%
|
13,232,652
|
$284,766,671 | $0 | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13D/G
13F
|
Company |
7.7%
|
8,104,869
|
$171,336,931 | $0 | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
5.4%
from 13D/G
|
5,304,907
|
$102,225,558 | — | 30 Sep 2025 | |
| D. E. SHAW & CO, L.P. |
13D/G
|
— |
1.9%
|
2,007,025
|
$38,675,372 | -$58,829,132 | 30 Sep 2025 | |
| Capital International Investors |
13D/G
|
— |
0.5%
|
524,146
|
$9,523,733 | -$152,120,639 | 30 Jun 2025 | |
| Douglas S. Ingram |
3/4/5
|
Chief Executive Officer, Director |
0.88%
|
929,391
|
$16,729,038 | — | 07 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
10%
|
10,817,446
|
$208,452,185 | — | 30 Sep 2025 | |
| Erste Asset Management GmbH |
13F
|
Company |
2.6%
|
2,685,945
|
$50,588,160 | — | 30 Sep 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.5%
|
2,650,178
|
$51,068,930 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2%
|
2,137,764
|
$41,194,712 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.9%
|
2,007,025
|
$38,675,372 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
1.9%
|
1,990,508
|
$38,357,088 | — | 30 Sep 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.9%
|
1,982,764
|
$38,207,862 | — | 30 Sep 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
1.9%
|
1,958,034
|
$37,731,315 | — | 30 Sep 2025 | |
| MORGAN STANLEY |
13F
|
Company |
1.9%
|
1,948,359
|
$37,544,892 | — | 30 Sep 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
1.8%
|
1,939,781
|
$37,379,579 | — | 30 Sep 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
1.7%
|
1,781,348
|
$34,326,576 | — | 30 Sep 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
1.7%
|
1,745,051
|
$33,627,133 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,721,124
|
$33,172,867 | — | 30 Sep 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
1.3%
|
1,366,690
|
$26,337,000 | — | 30 Sep 2025 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
1.2%
|
1,308,738
|
$25,219,381 | — | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
1.2%
|
1,308,691
|
$25,218,476 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.97%
|
1,018,922
|
$19,634,627 | — | 30 Sep 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.94%
|
990,866
|
$19,093,988 | — | 30 Sep 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.94%
|
990,000
|
$19,077,300 | — | 30 Sep 2025 | |
| Amundi |
13F
|
Individual |
0.92%
|
969,826
|
$22,558,153 | — | 30 Sep 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.79%
|
832,638
|
$16,044,935 | — | 30 Sep 2025 | |
| BRAIDWELL LP |
13F
|
Company |
0.79%
|
832,100
|
$16,034,567 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.76%
|
803,058
|
$15,474,923 | — | 30 Sep 2025 | |
| CAPITAL FUND MANAGEMENT S.A. |
13F
|
Company |
0.74%
|
780,054
|
$15,031,640 | — | 30 Sep 2025 | |
| MPM BioImpact LLC |
13F
|
Company |
0.67%
|
700,000
|
$13,489,000 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.64%
|
669,382
|
$12,899,376 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.62%
|
651,598
|
$12,554,551 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
638,780
|
$12,309,291 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
609,151
|
$11,738,340 | — | 30 Sep 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.57%
|
600,000
|
$11,562,000 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.56%
|
590,271
|
$11,374,521 | — | 30 Sep 2025 | |
| Opaleye Management Inc. |
13F
|
Company |
0.56%
|
585,000
|
$11,272,950 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.49%
|
512,477
|
$9,875,431 | — | 30 Sep 2025 | |
| Voleon Capital Management LP |
13F
|
Company |
0.48%
|
501,142
|
$9,657,006 | — | 30 Sep 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.48%
|
499,621
|
$9,628,000 | — | 30 Sep 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.47%
|
490,329
|
$9,449,000 | — | 30 Sep 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.45%
|
468,067
|
$9,019,651 | — | 30 Sep 2025 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.36%
|
381,172
|
$7,345,184 | — | 30 Sep 2025 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.36%
|
376,244
|
$7,250,222 | — | 30 Sep 2025 | |
| Bridgewater Associates, LP |
13F
|
Company |
0.34%
|
352,275
|
$6,788,339 | — | 30 Sep 2025 | |
| ALGERT GLOBAL LLC |
13F
|
Company |
0.33%
|
351,984
|
$6,783,000 | — | 30 Sep 2025 | |
| ADAR1 Capital Management, LLC |
13F
|
Company |
0.33%
|
349,807
|
$6,740,781 | — | 30 Sep 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.31%
|
328,576
|
$6,331,656 | — | 30 Sep 2025 | |
| CANADA PENSION PLAN INVESTMENT BOARD |
13F
|
Company |
0.31%
|
321,729
|
$6,199,718 | — | 30 Sep 2025 |
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock (SRPT) as of Q4 2025
As of 31 Dec 2025,
Sarepta Therapeutics, Inc. - Common Stock (SRPT) was held by
343 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
93,387,845 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, STATE STREET CORP, Erste Asset Management GmbH, TWO SIGMA INVESTMENTS, LP, Aberdeen Group plc, TWO SIGMA ADVISERS, LP, UBS Group AG, and FIRST TRUST ADVISORS LP.
This page lists
343
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
313
Q4 2025 holders
343
Holder diff
30
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.